Constitutively active ras negatively regulates Erk MAP kinase through induction of MAP kinase phosphatase 3 (MKP3) in NIH3T3 cells

BMB Reports

Volumn 47, Issue 12, 2014, Pages 685-690

  Park, Young Jae ^a   Lee, Jong Min ^b   Shin, Soon Young ^b   Kim, Young Ho ^a  

^a Kyungpook National University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Active H ras; Mitogen activated protein kinase; Mitogen activated protein kinase phosphatase 3; NIH3T3 fibroblast; Phosphatidylinositol 3 kinase

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE 6; DUSP6 PROTEIN, MOUSE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE INHIBITOR; RAF PROTEIN; RAS PROTEIN;

3T3 CELL LINE; ANIMAL; DRUG EFFECTS; GENETICS; METABOLISM; MOUSE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; DUAL SPECIFICITY PHOSPHATASE 6; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NIH 3T3 CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RAF KINASES; RAS PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84905120238     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2014.47.12.017     Document Type: Article

References (32)

1. Macara, I. G., Lounsbury, K. M., Richards, S. A., McKiernan, C. and Bar-Sagi, D. (1996) The Ras superfamily of GTPases. FASEB. J. 10, 625-630.
2. Schaeffer, H. J. and Weber, M. J. (1999) Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell Biol. 19, 2435-2444.
3. Wellbrock, C., Karasarides, M. and Marais, R. (2004) The RAF proteins take centre stage. Nat. Rev. Mol. Cell Biol. 5, 875-885.
4. Chang, L. and Karin, M. (2001) Mammalian MAP kinase signalling cascades. Nature 410, 37-40.
5. Johnson, G. L. and Lapadat, R. (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38protein kinases. Science 298, 1911-1912.
6. Murphy, L. O. and Blenis, J. (2006) MAPK signal specificity: the right place at the right time. Trends. Biochem. Sci. 31, 268-275.
7. Traverse, S., Gomez, N., Paterson, H., Marshall, C. and Cohen, P. (1992) Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288 (Pt 2), 351-355.
8. Ramos, J. W. (2008) The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int. J. Biochem. Cell Biol. 40, 2707-2719.
9. Yip-Schneider, M. T., Lin, A., Barnard, D., Sweeney, C. J. and Marshall, M. S. (1999) Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite active K-ras expression. Int. J. Oncol. 15, 271-279.
10. Iida, M., Towatari, M., Nakao, A., Iida, H., Kiyoi, H., Nakano, Y., Tanimoto, M., Saito, H. and Naoe, T. (1999) Lack of constitutive activation of MAP kinase pathway in human acute myeloid leukemia cells with N-Ras mutation. Leukemia 13, 585-589.
11. Yip-Schneider, M. T., Lin, A. and Marshall, M. S. (2001) Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase- Biochem. Biophys. Res. Commun. 280, 992-997.
12. Luo, W. and Sharif, M. (1999) Stable expression of activated Ki-Ras does not constitutively activate the mitogen-activated protein kinase pathway but attenuates epidermal growth factor receptor activation in human astrocytoma cells. Int. J. Oncol. 14, 53-62.
13. Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Osterman, A., Godzik, A., Hunter, T., Dixon, J. and Mustelin, T. (2004) Protein tyrosine phosphatases in the human genome. Cell 117, 699-711.
14. Kondoh, K. and Nishida, E. (2007) Regulation of MAP kinases by MAP kinase phosphatases. Biochim. Biophys. Acta. 1773, 1227-1237.
15. Owens, D. M. and Keyse, S. M. (2007) Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26, 3203-3213.
16. Dickinson, R. J. and Keyse, S. M. (2006) Diverse physiological functions for dual-specificity MAP kinase phosphatases. J. Cell Sci. 119, 4607-4615.
17. Groom, L. A., Sneddon, A. A., Alessi, D. R., Dowd, S. and Keyse, S. M. (1996) Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J. 15, 3621-3632.
18. Muda, M., Boschert, U., Dickinson, R., Martinou, J. C., Martinou, I., Camps, M., Schlegel, W. and Arkinstall, S. (1996) MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J. Biol. Chem. 271, 4319-4326.
19. Muda, M., Theodosiou, A., Rodrigues, N., Boschert, U., Camps, M., Gillieron, C., Davies, K., Ashworth, A. and Arkinstall, S. (1996) The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J. Biol. Chem. 271, 27205-27208.
20. Shin, S. Y., Bahk, Y. Y., Ko, J., Chung, I. Y., Lee, Y. S., Downward, J., Eibel, H., Sharma, P. M., Olefsky, J. M., Kim, Y. H., Lee, B. and Lee, Y. H. (2006) Suppression of Egr-1 transcription through targeting of the serum response factor by active H-Ras. EMBO. J. 25, 1093-1103.
21. Ekerot, M., Stavridis, M. P., Delavaine, L., Mitchell, M. P., Staples, C., Owens, D. M., Keenan, I. D., Dickinson, R. J., Storey, K. G. and Keyse, S. M. (2008) Negative-feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by ERK1/2 and mediated by Ets factor binding to a conserved site within the DUSP6/MKP-3 gene promoter. Biochem. J. 412, 287-298.
22. Downward, J. (2003) Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3, 11-22.
23. Nunes-Xavier, C. E., Tarrega, C., Cejudo-Marin, R., Frijhoff, J., Sandin, A., Ostman, A. and Pulido, R. (2010) Differential up-regulation of MAP kinase phosphatases MKP3/DUSP6 and DUSP5 by Ets2 and c-Jun converge in the control of the growth arrest versus proliferation response of MCF-7 breast cancer cells to phorbol ester. J. Biol. Chem. 285, 26417-26430.
24. Furukawa, T., Tanji, E., Xu, S. and Horii, A. (2008) Feedback regulation of DUSP6 transcription responding to MAPK1 via ETS2 in human cells. Biochem Biophys Res. Commun. 377, 317-320.
25. Zhang, Z., Kobayashi, S., Borczuk, A. C., Leidner, R. S., Laframboise, T., Levine, A. D. and Halmos, B. (2010) Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of active ERK signaling in lung cancer cells. Carcinogenesis 31, 577-586.
26. Kawakami, Y., Rodriguez-Leon, J., Koth, C. M., Buscher, D., Itoh, T., Raya, A., Ng, J. K., Esteban, C. R., Takahashi, S., Henrique, D., Schwarz, M. F., Asahara, H. and Izpisua Belmonte, J. C. (2003) MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb. Nat. Cell Biol. 5, 513-519.
27. Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D. and Downward, J. (1994) Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370, 527-532.
28. Vasudevan, K. M., Burikhanov, R., Goswami, A. and Rangnekar, V. M. (2007) Suppression of PTEN expression is essential for antiapoptosis and cellular transformation by oncogenic Ras. Cancer Res. 67, 10343-10350.
29. Zimmermann, S. and Moelling, K. (1999) Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286, 1741-1744.
30. Rommel, C., Clarke, B. A., Zimmermann, S., Nunez, L., Rossman, R., Reid, K., Moelling, K., Yancopoulos, G. D. and Glass, D. J. (1999) Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286, 1738-1741.
31. McCormick, F. (1999) Signalling networks that cause cancer. Trends. Cell Biol. 9, M53-56.
32. Shin, S. Y., Kim, C. G. and Lee, Y. H. (2013) Egr-1 regulates the transcription of the BRCA1 gene by etoposide. BMB Rep. 46, 92-96.